| |||||||
| |||||||
| |||||||
1 | SENATE RESOLUTION
| ||||||
2 | WHEREAS, Pediatric acute-onset neuropsychiatric syndrome | ||||||
3 | (PANS) and pediatric autoimmune neuropsychiatric disorder | ||||||
4 | associated with streptococcal infection (PANDAS) create the | ||||||
5 | sudden onset of obsessive-compulsive disorder in children, | ||||||
6 | causing previously healthy and emotionally adjusted children | ||||||
7 | to experience severe anxiety and emotional disturbances; and
| ||||||
8 | WHEREAS, Children with PANS and PANDAS tend to manifest | ||||||
9 | some of the following symptoms: tics or other abnormal | ||||||
10 | movements, severe separation anxiety, generalized anxiety, | ||||||
11 | irritability, aggression, personality changes, ADHD, marked | ||||||
12 | deterioration in learning and school performance, and | ||||||
13 | developmental regression, including deterioration in | ||||||
14 | handwriting; and
| ||||||
15 | WHEREAS, PANS is broader than PANDAS as it includes not | ||||||
16 | only disorders associated with a preceding infection, such as | ||||||
17 | Mycoplasma Pneumoniae, Mono, Lyme, viruses, and more, but also | ||||||
18 | acute onset non-infectious triggers, such as environmental | ||||||
19 | factors and metabolic dysfunction; treatment plans similar to | ||||||
20 | those for PANDAS should be attempted; and
| ||||||
21 | WHEREAS, Children with PANS and PANDAS may experience | ||||||
22 | moderate to dramatic improvement with antibiotics, steroids, |
| |||||||
| |||||||
1 | intravenous immunoglobulin treatment, or plasmapheresis; and | ||||||
2 | WHEREAS, Researchers at the National Institute of Mental | ||||||
3 | Health, along with 13 Centers for Excellence throughout the | ||||||
4 | country, are currently engaged in extensive research to | ||||||
5 | elucidate the causes and develop further effective treatment | ||||||
6 | options for PANS and PANDAS; and
| ||||||
7 | WHEREAS, Researchers at Moleculera Labs at the University | ||||||
8 | of Oklahoma have developed PANS and PANDAS blood testing | ||||||
9 | procedures; and | ||||||
10 | WHEREAS, The expert members of the physicians specialty | ||||||
11 | society, the PANDAS Physicians Network, have developed and | ||||||
12 | published standard treatment methods; and | ||||||
13 | WHEREAS, The organization PANDAS/PANS Advocacy and Support | ||||||
14 | strives to build public awareness, educate medical providers | ||||||
15 | about the disorder and treatments for same, build support for | ||||||
16 | legislation involving the disorder, and provide support and | ||||||
17 | resources for families affected by PANDAS/PANS, in accordance | ||||||
18 | with section 501(c)(3); and
| ||||||
19 | WHEREAS, The actual number of children suffering from PANS | ||||||
20 | and PANDAS has been estimated to be approximately one out of | ||||||
21 | every 200 children in the United States; and
|
| |||||||
| |||||||
1 | WHEREAS, It is imperative that there be greater public | ||||||
2 | awareness of this serious health issue; therefore, be it
| ||||||
3 | RESOLVED, BY THE SENATE OF THE ONE HUNDREDTH GENERAL | ||||||
4 | ASSEMBLY OF THE STATE OF ILLINOIS, that we designate the date | ||||||
5 | of October 9 of 2017 and 2018 as PANS and PANDAS Awareness Day | ||||||
6 | in the State of Illinois; and be it further
| ||||||
7 | RESOLVED, That a suitable copy of this resolution be | ||||||
8 | presented to Wendy Nawara, President of PANDAS/PANS Advocacy | ||||||
9 | and Support of Illinois.
|